1 |
Baskin et al.. Lancet 2009;374:159–69. |
2 |
Center for Disease Control; https://www.cdc.gov/vitalsigns/protect-patients/infographic.html |
3 |
Hadaway, Lynn “Heparin Locking for Central Venous Catheters; JAVA, Volume 11 No 4 2006″ |
4 |
MISSING REFERENCE |
5 |
Liu et. al, mSphere, November/December 2018 Volume 3 Issue 6 e00525-18, 2018 |
6 |
Hill et al. 2020; manuscript pending |
7 |
https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/central-line-associated-bloodstream-infections-toolkit-and-monograph/ |
8 |
Moureau N, Poole S, Murdock MA, et al. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol 2002; 13(10):1009–16. |
9 |
Hill et al, 2020; manuscript pending |
10 |
Liu et. al, mSphere, November/December 2018 Volume 3 Issue 6 e00525-18, 2018 |
11 |
Quirt et al, 2020; manuscript pending |
12 |
https://pubmed.ncbi.nlm.nih.gov/29042186/#:~:text=Bacterial%20biofilms%20are%20usually%20pathogenic,are%20associated%20with%20biofilm%20formation |
13 |
https://theconversation.com/drug-resistant-superbugs-a-global-threat-intensified-by-the-fight-against-coronavirus-135790 |